Virtual Medicinal Product (VMP) - Methotrexate 5mg/2ml solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Methotrexate 5mg/2ml solution for injection vials Start Date 07-06-2004 End Date
Previous Name Previous Name Methotrexate 2.5mg/ml injection 2ml vials Start Date 13-01-2003 End Date 06-06-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2.0
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular, Intravenous, Intraarterial, Intrathecal
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.intravenous, solutioninjection.intraarterial, solutioninjection.intrathecal
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01BA01
BNF Start Date End Date
Current BNF 08010300 Start Date 04-04-2022 End Date
Previous BNF 08010300 Start Date 09-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36033611000001107 29-10-2018
326877000 19-08-2005 28-10-2018
3630611000001101 13-01-2003 18-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Methotrexate sodium Based on Base Substance Methotrexate 2.5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 vial